Risk of Fractures With Concomitant Use of Calcium Channel Blockers and Selective Serotonin Reuptake Inhibitors.

Desai, Raj; Smith, Steven M; Mohandas, Rajesh; Brown, Joshua; Park, Haesuk

Desai, Raj; Smith, Steven M; Mohandas, Rajesh; Brown, Joshua; Park, Haesuk.

Afiliação

Desai R; University of Florida College of Pharmacy, Gainesville, FL, USA.
Smith SM; University of Florida College of Pharmacy, Gainesville, FL, USA.
Mohandas R; LSU Health New Orleans, New Orleans, LA, USA.
Brown J; University of Florida College of Pharmacy, Gainesville, FL, USA.
Park H; University of Florida College of Pharmacy, Gainesville, FL, USA.

Ann Pharmacother ; : 10600280231218286, 2023 Dec 11.

Article em En | MEDLINE | ID: mdl-38078408

Palavras-chave

calcium channel blockers; concomitancy; concurrent use; fractures; medication safety; selective serotonin reuptake inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Ann Pharmacother Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google